三氯生涂层缝线预防手术部位感染的Meta分析与试验序贯分析
BACKGROUND: Triclosan-coated sutures (TCS) were developed to reduce the risk of surgical-site infection (SSI). Level 1A evidence of effectiveness has been presented in various recent meta-analyses, yet well designed RCTs have not been able to reproduce these favourable results.…
要点
- 在每1000例手术138例感染的风险下,使用涂层缝线可减少39例感染(95%CI 19-55)。
- GRADE评估为中等质量证据,试验序贯分析提示效应稳健。
核心结论
- GRADE评估显示中等质量证据表明三氯生涂层缝线可有效减少手术部位感染。
- 试验序贯分析提示该效应稳健,额外数据不太可能改变汇总效应。
研究设计与样本
- 纳入比较三氯生涂层缝线与相同但未涂层缝线预防手术部位感染的随机对照试验。
- 采用随机效应模型估计汇总相对风险及95%置信区间,使用Meta回归分析亚组效应,试验序贯分析评估随机误差风险,GRADE方法确定证据质量。
主要发现
- 偏倚风险为严重。
- 在每1000例手术138例手术部位感染的风险下,使用三氯生涂层缝线可减少39例感染(95%CI 19-55)。
- 试验序贯分析证实使用三氯生涂层缝线可降低15%的相对风险。
临床怎么用
- 基于中等质量证据,可考虑使用三氯生涂层缝线以降低手术部位感染风险。
- 试验序贯分析提示效应稳健,临床决策时可参考该证据。
局限性
- 纳入研究的偏倚风险为严重。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Triclosan-coated sutures (TCS) were developed to reduce the risk of surgical-site infection (SSI). Level 1A evidence of effectiveness has been presented in various recent meta-analyses, yet well designed RCTs have not been able to reproduce these favourable results. The aim of this study was to evaluate all available evidence critically with comprehensive analysis to seek a more reliable answer regarding the effectiveness of TCS in the prevention of SSI. METHODS: PubMed, MEDLINE, Embase and Cochrane Library databases were searched from 1990 to November 2015 for RCTs that compared TCS with sutures that were exactly the same, but uncoated, in the prevention of SSI. Pooled relative risks (RRs) with corresponding 95 per cent confidence intervals were estimated using a random-effects model. Metaregression was used to substantiate subgroup effects, trial sequential analysis was employed to assess the risk of random error, and quality of evidence was determined using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. RESULTS: Twenty-one RCTs including 6462 patients were included. Risk of bias was serious. Pooled effects showed a RR of 0·72 (95 per cent c.i. 0·60 to 0·86; P < 0·001) for all publications. At a risk of 138 SSIs per 1000 procedures, the use of TCS reduced this by 39 (95 per cent c.i. 19, 55). Trial sequential analysis confirmed a RR reduction of 15 per cent for the use of TCS. CONCLUSION: GRADE assessment shows moderate-quality evidence that TCS are effective in reducing SSI. Trial sequential analysis indicates that the effect was robust, and additional data are unlikely to alter the summary effect.
引用
- de Jonge SW, Atema JJ, Solomkin JS, et al. Meta-analysis and trial sequential analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg. 2017. PMID: 28093723. doi:10.1002/bjs.10445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。